McKesson
MCK
#229
Rank
HK$624.98 B
Marketcap
HK$4,987
Share price
0.32%
Change (1 day)
21.39%
Change (1 year)
McKesson Corporation is an American company distributing pharmaceuticals and providing health information technology, medical supplies, and care management tools.

P/E ratio for McKesson (MCK)

P/E ratio as of March 2025 (TTM): 25.2

According to McKesson's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 25.1841. At the end of 2022 the company had a P/E ratio of 17.1.

P/E ratio history for McKesson from 2001 to 2023

PE ratio at the end of each year

Year P/E ratio Change
202217.1-38.33%
202127.6-526.7%
2020-6.48-77.19%
2019-28.4-65.8%
2018-83.1-1311.15%
20176.86-58.3%
201616.4-29.29%
201523.3-16.97%
201428.0-12.7%
201332.1122.06%
201214.5-3.37%
201115.0-8.85%
201016.416.28%
200914.110.74%
200812.7-37.96%
200720.518.27%
200617.4-11.49%
200519.6-141.78%
2004-47.0-408.07%
200315.2-1.88%
200215.5-82.97%
200191.2

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
126 399.33%๐Ÿ‡บ๐Ÿ‡ธ USA
21.7-13.79%๐Ÿ‡บ๐Ÿ‡ธ USA
21.1-16.03%๐Ÿ‡บ๐Ÿ‡ธ USA
10.7-57.51%๐Ÿ‡บ๐Ÿ‡ธ USA
47.5 88.45%๐Ÿ‡บ๐Ÿ‡ธ USA
27.8 10.58%๐Ÿ‡บ๐Ÿ‡ธ USA
-7.73-130.69%๐Ÿ‡บ๐Ÿ‡ธ USA
14.1-44.09%๐Ÿ‡บ๐Ÿ‡ธ USA
11.4-54.75%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.